Erectile Dysfunction Market Report 2024 (Global Edition)

Global Erectile Dysfunction Market Report 2024 Market Size Split by Type (ED Drugs, ED Devices), by Application (Congenital Patients, Pathological Patients), by End User (Hospitals and ASCs, Clinics),...

Erectile Dysfunction Market Report Description

We have various report editions of Erectile Dysfunction Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Erectile Dysfunction market

The competitive landscape of the erectile dysfunction (ED) market is characterized by intense competition among pharmaceutical companies and medical device manufacturers striving to gain a competitive edge through product innovation, strategic partnerships, and marketing strategies.

Erectile Dysfunction Industry News 

In September 2022, Advanced MedTech Holdings (Singapore) acquired Shenzhen Huikang Medical Apparatus Co., Ltd. (China). This acquisition expanded Advanced MedTech's urological market access in China via comprehensive nationwide sales and service network and an established local R&D, manufacturing, and supply chain ecosystem.

(Source: https://eswl.com/press-release-advanced-medtech-acquires-wikkon-strengthening-its-market-leading-position-in-urology-medical-devices/)

In April 2022, Wikkon's extracorporeal shock wave lithotripter, model HK.ESWL-108A was successfully installed at Maria Clinic, Dili, and East Timor.

(Source: https://eswl.com/wikkons-first-eswl-installation-in-east-timor/)

Top Companies Market Share in Erectile Dysfunction Industry: (In no particular order of Rank)

• Coloplast
• Boston Scientific
• Pfizer
• Eli Lilly and Company
• Teva Pharmaceuticals
• Bayer
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Erectile dysfunction Market

Which Region Dominates the erectile dysfunction Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. North America stands as the dominant region in the erectile dysfunction (ED) market due to several key factors. Firstly, the region boasts a large population of aging individuals, who are more susceptible to experiencing ED. Additionally, North America is home to several major pharmaceutical companies that have developed and marketed popular ED medications, including sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra), contributing to the region's dominance in this market. Furthermore, the healthcare infrastructure in North America is well-developed, with widespread access to healthcare services and prescription medications, facilitating the diagnosis and treatment of ED.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific emerges as the fastest-growing region in the erectile dysfunction (ED) market owing to several significant factors. Firstly, there is a growing awareness and acceptance of ED as a medical condition in many countries across the Asia-Pacific region. This increasing awareness has led to more individuals seeking diagnosis and treatment for ED, thereby driving market growth. Additionally, the rapidly expanding aging population in countries like Japan, China, and India contributes to the rising prevalence of ED, as age is a significant risk factor for this condition.

The current report Scope analyzes Erectile Dysfunction Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Erectile Dysfunction Market

According to Cognitive Market Research, the global Erectile Dysfunction market size was estimated at USD 4681.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1872.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.In the North America region, the erectile dysfunction (ED) system market exhibits robust growth driven by several factors. With a high prevalence of ED cases and a growing aging population, North America represents a significant market for ED treatments. Segmentation analysis reveals that the market comprises both ED drugs and devices, with a notable preference for advanced therapeutic options such as penile implants and vacuum erection devices. In terms of regional analysis, the United States dominates the North American ED system market, primarily due to its large population base and high healthcare expenditure. The country's advanced medical technology sector and research facilities contribute to the development and adoption of innovative ED treatments. In conclusion, the North America region presents lucrative opportunities for stakeholders in the erectile dysfunction system market. Continued investments in research and development, coupled with efforts to address unmet medical needs and improve patient outcomes, are expected to drive market expansion further.

Country Analysis

• According to Cognitive Market Research, the US had a major share in the Erectile Dysfunctions market with a market size of USD 1477.39 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The demand is amplified by the nation's large population base and high healthcare expenditure propel consistent growth. 
• The Canada Erectile Dysfunctions market had a market share of USD 224.70 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Canada's rising investments in research and development.
• The Mexico Erectile Dysfunctions market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD 170.40 million in 2024.

 

Europe Erectile Dysfunction Market

According to Cognitive Market Research the global Erectile Dysfunction market size was estimated at USD 4681.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 1404.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.In the European region, the erectile dysfunction (ED) system market demonstrates significant growth prospects driven by various factors. Regional analysis indicates that Europe boasts a sizable population affected by ED, primarily due to factors such as aging demographics and lifestyle-related issues. Segmentation analysis reveals a diverse market landscape comprising both pharmaceutical and device-based interventions for ED treatment. Key markets in Europe include Germany, the United Kingdom, and France, which collectively account for a substantial share of the regional ED system market. These countries benefit from well-established healthcare systems, high patient awareness, and favourable reimbursement policies, facilitating access to a wide range of treatment options for individuals with ED. In conclusion, the European region presents significant growth opportunities for stakeholders in the ED system market. Continued investments in research and development, along with initiatives to address the psychosocial aspects of ED and reduce stigma surrounding the condition, are expected to drive market expansion further.

• The United Kingdom Erectile Dysfunctions market had a market share of USD 235.93million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In the UK, Erectile Dysfunction sales witness an upswing due to the nation's Continued investments in research and development.
• The France Erectile Dysfunctions market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 129.20million in 2024.
• According to Cognitive Market Research, the Germany Erectile Dysfunctions market size was valued at USD 278.06million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. In Germany, Erectile Dysfunction sales surge due to the nation's aging demographics and lifestyle-related issues. 
• The Italy Erectile Dysfunctions market is projected to witness growth at a CAGR of 5.9% during the forecast period with a market size of USD 120.77million in 2024.
• The Russia Erectile Dysfunctions market is projected to witness growth at a CAGR of 5.5% during the forecast period with a market size of USD 217.68million in 2024.
• The Spain Erectile Dysfunctions market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 115.16million in 2024.
• The Luxembourg Erectile Dysfunctions market is projected to witness growth at a CAGR of 6.6% during the forecast period with a market size of USD 43.54 million in 2024.
• The Portugal Erectile Dysfunctions market is projected to witness growth at a CAGR of 6.3% during the forecast period with a market size of USD 29.49million in 2024.
• The Greece Erectile Dysfunctions market is projected to witness growth at a CAGR of 6.8% during the forecast period with a market size of USD 16.85million in 2024.
• Rest of Europe Erectile Dysfunctions market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD 217.68million in 2024.

 

Asia Pacific Erectile Dysfunction Market

According to Cognitive Market Research, the global Erectile Dysfunction market size was estimated at USD 4681.2 Million out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD 1076.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

In the Asia-Pacific region, the erectile dysfunction (ED) system market is witnessing significant growth attributed to various factors. Regional analysis indicates a rising prevalence of ED cases due to lifestyle changes, increasing stress levels, and aging populations across countries in Asia-Pacific. This demographic trend, coupled with growing awareness about ED treatments and improving healthcare infrastructure, is driving market expansion. Segmentation analysis reveals a diverse market landscape, with both ED drugs and devices being widely utilized. Countries like China, India, and Japan are key contributors to the Asia-Pacific ED system market, fuelled by large patient populations and expanding healthcare expenditure. In these markets, technological advancements and the availability of affordable treatment options are driving adoption rates. In conclusion, the Asia-Pacific region presents immense opportunities for stakeholders in the erectile dysfunction system market. Continued investments in healthcare infrastructure, research and development, and educational initiatives are essential to meet the growing demand for ED treatment.

• According to Cognitive Market Research, the China Erectile Dysfunctions market size was valued at USD 484.50 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Erectile Dysfunction sales surge in China due to the growing awareness about ED treatments and improving healthcare infrastructure.
• The Japan Erectile Dysfunctions market is projected to witness growth at a CAGR of 8.5% during the forecast period with a market size of USD 148.58 million in 2024.
• The India Erectile Dysfunctions market had a market share of USD 129.20 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. The demand is augmented by India's improving healthcare infrastructure.
• The South Korea Erectile Dysfunctions market is projected to witness growth at a CAGR of 9.1% during the forecast period with a market size of USD 107.67 million in 2024.
• The Australia Erectile Dysfunctions market is projected to witness growth at a CAGR of 9.7%during the forecast period with a market size of USD 55.99 million in 2024.
• The South East Asia Erectile Dysfunctions market is projected to witness growth at a CAGR of 11.0% during the forecast period with a market size of USD 74.29 million in 2024.
• The Rest of Asia Pacific Erectile Dysfunctions market is projected to witness growth at a CAGR of 9.8% during the forecast period with a market size of USD 76.44 million in 2024.

 

South America Erectile Dysfunction Market

According to Cognitive Market Research, the global Erectile Dysfunctions market size was estimated at USD 4681.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 234.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.In the Latin America region, the erectile dysfunction (ED) system market is experiencing steady growth, driven by various factors specific to the region. Regional analysis indicates a growing awareness of sexual health issues and an increasing willingness among patients to seek treatment for ED. Countries like Brazil, Mexico, and Argentina are witnessing significant market demand, propelled by rising healthcare expenditure and expanding access to healthcare services. Segmentation analysis reveals a diverse market landscape, with both ED drugs and devices being widely utilized. Pharmaceutical interventions such as phosphodiesterase inhibitors (PDE5 inhibitors) remain the primary treatment option, but there is a growing demand for non-invasive therapies like vacuum erection devices and penile implants. In conclusion, the Latin America region presents promising opportunities for stakeholders in the erectile dysfunction system market. Continued investments in healthcare infrastructure, medical education, and awareness campaigns are crucial to address the unmet needs of patients with ED.

• According to Cognitive Market Research, the Brazil Erectile Dysfunctions market size was valued at USD 100.18million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Erectile Dysfunction sales flourish in Brazil due to the nation's investments in healthcare infrastructure, medical education, and awareness campaigns.
• The Argentina Erectile Dysfunctions market had a market share of USD 39.32million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. The demand is augmented by Argentina's medical education, and awareness campaigns.
• The Colombia Erectile Dysfunctions market is projected to witness growth at a CAGR of 7.2% during the forecast period with a market size of USD 20.83million in 2024.
• The Peru Erectile Dysfunctions market is projected to witness growth at a CAGR of 7.6% during the forecast period with a market size of USD 19.19million in 2024.
• The Chile Erectile Dysfunctions market is projected to witness growth at a CAGR of 7.7% during the forecast period with a market size of USD 16.85million in 2024.
• The Rest of Latin America Erectile Dysfunctions market is projected to witness growth at a CAGR of 6.5% during the forecast period with a market size of USD 37.68million in 2024.

 

Middle East and Africa Erectile Dysfunction Market

According to Cognitive Market Research, the global Erectile Dysfunction market size was estimated at USD 4681.2 Million out of which Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD 93.62 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.In the Middle East and Africa (MEA) region, the erectile dysfunction (ED) system market reflects a mix of opportunities and challenges. Regional analysis indicates that cultural and societal factors influence the prevalence of ED, with varying levels of awareness and acceptance of sexual health issues across different countries. Segmentation analysis reveals a market dominated by ED drugs, particularly phosphodiesterase inhibitors (PDE5 inhibitors) like sildenafil and tadalafil. However, there is growing interest in non-pharmaceutical approaches such as vacuum erection devices and penile implants, driven by advancements in medical technology and increasing patient preference for non-invasive treatments. In conclusion, the MEA region presents a complex landscape for the erectile dysfunction system market. Addressing cultural taboos and stigma associated with ED is crucial for improving awareness and access to treatment.

• According to Cognitive Market Research, the GCC Countries Erectile Dysfunctions market size was valued at USD 40.07 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Erectile Dysfunction sales flourish in the GCC Countries due to the region's improving awareness and access to treatment.
• The Egypt Erectile Dysfunctions market is projected to witness growth at a CAGR of 8.0% during the forecast period with a market size of USD 9.83 million in 2024.
• The South Africa Erectile Dysfunctions market is projected to witness growth at a CAGR of 8.7%during the forecast period with a market size of USD 14.79 million in 2024.Erectile Dysfunction sales flourish in the South Africa due to the region's medical education, and awareness campaigns.
• The Turkey Erectile Dysfunctions market is projected to witness growth at a CAGR of 7.2% during the forecast period with a market size of USD 8.05 million in 2024.
• The Nigeria Erectile Dysfunctions market is projected to witness growth at a CAGR of 6.8% during the forecast period with a market size of USD 9.83 million in 2024.
• The Rest of MEA Erectile Dysfunctions market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD 11.05million in 2024.

 

Erectile Dysfunction Market Analysis

Erectile dysfunction Type Segment Analysis

According to Cognitive Market Research, ED drugs represent the dominating category due to their widespread usage and high demand. ED drugs, such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra), are widely prescribed by healthcare professionals worldwide for the treatment of ED. These medications are often the first-line treatment option for individuals experiencing ED symptoms, offering a convenient and effective solution for many patients. Moreover, pharmaceutical companies invest heavily in research and development to introduce newer and more effective ED drugs, maintaining the dominance of this category in the market.

ED devices emerge as the fastest-growing category in the market. ED devices include vacuum erection devices (VEDs), penile implants, and external penile support devices. These devices offer alternative treatment options for individuals who do not respond well to or cannot use ED drugs due to medical reasons. Moreover, technological advancements in ED devices, such as improved design, ease of use, and better efficacy, contribute to their increasing adoption among patients and healthcare providers. Additionally, the growing awareness of non-pharmacological treatment options for ED drives the demand for ED devices, making this category the fastest-growing segment in the market.

• ED Drugs
• ED Devices

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Erectile Dysfunction Industry. Request a Free Sample PDF!

Erectile dysfunction Application Segment Analysis

According to Cognitive Market Research, pathological patients represent the dominating category. Pathological patients refer to individuals who develop ED due to underlying medical conditions such as diabetes, cardiovascular diseases, neurological disorders, and hormonal imbalances. These patients constitute a significant portion of the ED patient population and often require medical intervention to manage their condition effectively. As a result, pharmaceutical companies focus on developing medications and therapies specifically tailored to address the underlying causes of ED in pathological patients. Moreover, healthcare professionals emphasize the importance of diagnosing and treating the underlying medical conditions to improve erectile function, further solidifying the dominance of this category in the market.

Congenital patients represent the fastest-growing category in the ED market. Congenital patients refer to individuals who experience ED as a result of congenital or developmental abnormalities affecting their reproductive system. While congenital ED is relatively rare compared to acquired forms of the condition, advancements in medical technology and surgical techniques have made it possible to diagnose and treat congenital ED more effectively. Additionally, increasing awareness and acceptance of congenital ED among patients and healthcare providers contribute to the growing demand for specialized treatments and interventions tailored to this patient population.

• Congenital Patients
• Pathological Patients

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Erectile Dysfunction End User Segment Analysis

According to Cognitive Market Research, hospitals and ambulatory surgical centers (ASCs) represent the dominating category in terms of end users. These healthcare facilities are equipped with advanced diagnostic tools and treatment options, making them the primary choice for patients seeking comprehensive care for ED. Hospitals and ASCs offer a wide range of services, including consultations with specialists, diagnostic tests, medical interventions, and surgical procedures, ensuring that patients receive personalized and effective treatment for their condition. Additionally, these facilities often collaborate with pharmaceutical companies and medical device manufacturers to conduct research and clinical trials, further solidifying their dominance in the ED market.

Clinics emerge as the fastest-growing category in the ED market. Clinics specializing in men's health and sexual wellness have witnessed a significant surge in demand due to several factors. Firstly, clinics offer a more accessible and discreet environment for patients to discuss their sexual health concerns and seek treatment for ED. This increased accessibility encourages more individuals to seek medical help for their condition, contributing to the growth of the clinic segment. Furthermore, clinics often employ multidisciplinary teams of healthcare professionals, including urologists, endocrinologists, and psychologists, who collaborate to provide comprehensive and personalized care for ED patients. The combination of specialized expertise and patient-centered care offered by clinics makes them increasingly attractive to individuals seeking effective solutions for erectile dysfunction, thereby driving the growth of this segment in the market.

• Hospitals and ASCs
• Clinics

Erectile Dysfunction Distribution Channel Segment Analysis

According to Cognitive Market Research, retail pharmacies emerge as the dominating category in terms of distribution channels. Retail pharmacies are widely accessible to consumers, with numerous locations in urban, suburban, and rural areas, making them convenient destinations for purchasing ED medications and related products. Patients often visit retail pharmacies to fill prescriptions provided by healthcare providers or to purchase over-the-counter remedies for ED symptoms. Additionally, retail pharmacies typically offer a range of health services, including counselling on medication use and potential side effects, which further enhances their appeal to ED patients. The widespread presence and comprehensive services offered by retail pharmacies contribute to their dominance in the distribution of ED products.

Online portals represent the fastest-growing category in the distribution of ED products. The increasing prevalence of e-commerce platforms and online pharmacies has transformed the way consumers access healthcare products, including those related to erectile dysfunction. Online portals offer the convenience of purchasing ED medications and supplements from the comfort and privacy of home, eliminating the need for in-person visits to traditional brick-and-mortar pharmacies. Moreover, online portals often provide a wider selection of products, competitive pricing, and discreet packaging options, attracting a growing number of consumers seeking convenient and confidential solutions for their ED needs. The convenience, accessibility, and discretion offered by online portals contribute to their rapid growth as a preferred distribution channel for ED products.

• Retail Pharmacies
• Hospital Pharmacies
• Online Portals

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion